Iran vs Nigeria: Cause of death, by non-communicable diseases, ages 60+, female
Iran
67.8%
in 2021
Nigeria
67.2%
in 2021
Iran rank
135th
Nigeria rank
138th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Iran
- Nigeria
How they compare
Iran currently reports 67.8% against 67.2% in Nigeria, a difference of 0.6%.
Across all 6 years both countries report, Iran has been ahead every year.
Iran ranks 135th and Nigeria ranks 138th of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 60.5% | 34.3% | Iran |
| 2010s | 94.9% | 63.9% | 30.9% | Iran |
| 2020s | 70.6% | 65.9% | 4.7% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Iran or Nigeria?
- Iran, at 67.8% against 67.2% in Nigeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Iran and Nigeria?
- 0.6%, with Iran ahead.
- How many years of comparable data are there for Iran and Nigeria?
- 6 years are reported by both, from 2000 to 2021.
- How do Iran and Nigeria rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Iran ranks 135th and Nigeria ranks 138th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.